Clinical Trial Update: Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating lenvatinib for Adenoid cystic carcinoma. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING